Abstract
ObjectivesTo examine whether a high positive end-expiratory pressure (PEEP ≥5 cmH2O) has a protective effect on the risk of postoperative pulmonary complications (PPCs) in a cohort of patients living at high altitudes and undergoing general anaesthesia.DesignRetrospective, observational study.SettingA tertiary hospital in China.ParticipantsAdult Tibetan patients living at high altitudes (≥3000 m) and who went to the low-altitude plain to undergo non-cardiothoracic surgery under general anaesthesia, from January 2018 to April 2020.MeasurementsThis study included 1905 patients who were divided according to the application of an intraoperative PEEP: low PEEP (<5 cmH2O, including 0 cmH2O) or high PEEP (≥5 cmH2O). The primary outcome was a composite of PPCs within the first 7 postoperative days. The secondary outcomes included reintubation and unplanned intensive care unit (ICU) admission within the first 7 postoperative days and total hospital stays (day).ResultsThe study included 1032 patients in the low PEEP group and 873 in the high PEEP group. There were no differences in the incidence of PPCs between the high and low PEEP groups (relative risk (RR) 0.913; 95% CI 0.716 to 1.165; p=0.465). After propensity score matching, 643 patients remained in each group, and the incidence of PPCs in the low PEEP group (18.0%) was higher than in the high PEEP group (13.7%; RR 0.720; 95% CI 0.533 to 0.974; p=0.033). There were no differences in the incidence of reintubation, unplanned ICU admission or hospital stays. The risk factors of PPCs derived from multiple regression showed that the application of >5 cmH2O PEEP during intraoperative mechanical ventilation was associated with a significantly lower risk of PPCs in patients from a high altitude (OR=0.725, 95% CI 0.530 to 0.992; p=0.044).ConclusionsThe application of PEEP ≥5 cmH2O during intraoperative mechanical ventilation in patients living at high altitudes and undergoing surgery at low altitudes may be associated with a lower risk of PPCs. Prospective longitudinal studies are needed to further investigate perioperative lung protection ventilation strategies for patients from high altitudes.Trial registration numberChinese Clinical Trial Registry (ChiCTR2100044260).
Funder
natural science foundation of the Tibetan Autonomous Region of 2021
Reference39 articles.
1. Wilderness medical society clinical practice guidelines for the prevention and treatment of acute altitude illness: 2019 update;Luks;Wilderness Environ Med,2019
2. School of Human Kinetics PDD, University of British Columbia . Acclimatisation, de-acclimatisation and re-acclimatisation to hypoxia. Vancouver: MacNutt MJ, 2011: 16–23.
3. Respiratory health benefits and risks of living at moderate altitude;Grissom;High Alt Med Biol,2018
4. Efficacy of shenqi pollen capsules for high-altitude deacclimatization syndrome via suppression of the reoxygenation injury and inflammatory response;He;J Immunol Res,2019
5. He B , Wang J , Qian G , et al . Analysis of high-altitude de-acclimatization syndrome after exposure to high altitudes: a cluster-randomized controlled trial. PLoS One 2013;8:e62072.doi:10.1371/journal.pone.0062072